A recent analyst has expressed concern over UnitedHealth Group’s future, citing rising regulatory scrutiny and increasing competition in the health insurance market. The largest US health insurer by membership had previously experienced years of double-digit revenue growth, with shares reaching a record high in November 2023. However, one analyst believes that these positive trends may be short-lived as the company faces growing challenges ahead.
Source: https://www.bloomberg.com/news/newsletters/2025-05-22/why-one-wall-street-analyst-bravely-downgraded-unitedhealth-in-february